
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
Telo Genomics closes first tranche for $840,000
Noveris Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances
Victory Square Provides Corporate Update on Healthcare Infrastructure Strategy and Portfolio Developments
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Eupraxia Pharmaceuticals Announces Proposed Public Offering
MindBio Announces Private Placement to Raise up to $650,000
MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform
Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC
Marvel Biosciences Secures Funding to Develop Child-Friendly Liquid Formulation for Neurodevelopmental Disorders
Cheelcare Closes $1.0 Million Unsecured Note Financing
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO(TM) (Axatilimab) in Brazil
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
Telo Genomics Closes First Tranche of Convertible Debentures Financing
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance